Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy

TY - JOUR

T1 - Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy

AU - MENTOR study Investigators

AU - Sethi, Amit

AU - Miao, Jing

AU - Willrich, Maria Alice V

AU - Frinack, Jody L

AU - Cattran, Daniel C

AU - Fervenza, Fernando C

AU - Brenchley, Paul

N1 - Funding Information: The Membranous Nephropathy Trial of Rituximab (MENTOR) was supported by the Fulk Family Foundation and Genentech Inc. Funding Information: The study was funded by the Mayo Nephrology Collaborative Group – Mayo Clinic Foundation and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

PY - 2021/6/11

Y1 - 2021/6/11

UR - https://www.scopus.com/pages/publications/85108304215

U2 - 10.2215/CJN.16631020

DO - 10.2215/CJN.16631020

M3 - Letter

C2 - 33858828

SN - 1555-9041

VL - 16

SP - 939

EP - 941

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

IS - 6

ER -